As more pharmaceutical businesses contemplate outsourcing services, the need for services from contract manufacturing and contract development manufacturing organizations will grow. Future Industry Insights (FMI) believes that the CMO/CDMO Market has enormous potential for growth in the foreseeable future. The increased need for generic pharmaceuticals and biologics will fuel market expansion. Contract manufacturing accounts for …
Continue reading “CMO/CDMO Market is threatened by the risk of intellectual property loss | FMI”